Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

BMO Capital Analyst Updates and Downgrades Galiano Gold Ingevity Corp and Gold Fields Ltd ADR

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Finance_ Stock Trading (2)
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

BMO Capital analyst Raj Ray is bullish on Galiano Gold (AMEX:GAU) as he maintains an Outperform rating and increases the price target to $2.25. This optimistic stance reflects confidence in the company’s potential for growth. Galiano Gold, previously known as Asanko Gold, Inc., focuses on acquiring and exploring mineral resources in West Ghana.

On the other hand, BMO Capital Market analyst John P. McNulty has downgraded Ingevity Corp (NYSE:NGVT) from Outperform to Market Perform, setting a lower price target of $60 from $71. This downgrade is attributed to challenges in the CTO market, with McNulty foreseeing cost headwinds for NGVT’s Performance Chemicals segment. Issues such as pricing pressures and supply constraints in the European biofuels market are expected to impact NGVT’s financial performance in the coming years.

Furthermore, BMO Capital Markets has downgraded Gold Fields Ltd ADR (NYSE:GFI) from Market Perform to Underperform, revising the price target to $12 from $14. This downgrade indicates a less favorable outlook for Gold Fields Ltd ADR stock based on BMO Capital Markets’ analysis.

These recent updates offer valuable insights into the shifting recommendations and price targets for these companies, reflecting analysts’ evaluations of their performance and the prevailing market conditions.

GAU Stock Price Update: March 7, 2024 – Minor Decrease and Stable After-Hours Trading

On March 7, 2024, GAU stock experienced a slight decrease in its price, closing at $1.11. This represents a drop of $0.02, or 1.77%, since the market last closed. Despite this decrease, GAU is still trading in the middle of its 52-week range and above its 200-day simple moving average.

The stock remained unchanged in after-hours trading, indicating that there was no significant movement in its price after the market closed. This stability could suggest that investors are holding onto their positions and waiting for more information before making any significant moves. Investors will likely continue to monitor the stock closely to see if any new developments impact its performance in the coming days.

GAU Stock Performance Analysis: Decrease in Net Income and EPS on March 7, 2024

On March 7, 2024, GAU stock experienced mixed performances based on the financial data provided by CNN Money. The net income for GAU was reported at $26.09 million for the past year, but it decreased by 36.08% compared to the previous year. In the last quarter, the net income was -$5.76 million, showing a slight improvement of 0.0% compared to the previous quarter.

Earnings per share (EPS) for GAU were reported at $0.12 for the past year, but it decreased by 36.16% compared to the previous year. In the last quarter, the EPS was -$0.03, indicating a significant decrease of 150.59% compared to the previous quarter.

Overall, GAU stock performances on March 7, 2024, were impacted by the decrease in net income and earnings per share. Investors may have reacted to these financial indicators by adjusting their positions in the stock. It is essential for investors to closely monitor the financial performance of GAU and consider the potential risks and opportunities associated with investing in the company. Further insights into the company’s total revenue and future earnings projections may provide a more comprehensive understanding of GAU’s stock performances.

Tags: GAU
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Aerospace and Defense Market Capitalization

NPS Receives 175 Million in Funding to Enhance Radar Technology

Technology Blockchain Stock Market Today

Analyst Reiterates Outperform Rating for GoDaddy with 124 Price Target

Biotechnology Trading online

Evogene Ltd Reports Record Revenue Growth in 2023 Expands Partnerships and Plans Strategic Shift

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com